This report studies the global cell analysis market over the forecast period of 2013 to 2018. The global cell analysis market was valued at an estimated $16.7 billion in 2013 and is expected to reach $23.0 billion by 2018, growing at a CAGR of 6.6% from 2013 to 2018.
Download Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=157543946
The cell analysis market is expected to witness a reasonable growth in the forecast period. This growth can be attributed to a number of factors such as the rising incidence of cancer. Furthermore, government bodies have extended their help in the form of investments, grants, and funds for cell-based research activities. This has provided the required stimulus for growth in this market. For instance, the German government, through the BioMet network, funded the Max Planck Institute of Molecular Cell Biology and Genetics (Germany) for industry-academic collaborations in Europe in the area of high content screening. Furthermore, various factors such as better informatics services and the availability of improved reagents and image analysis instruments are propelling the growth of this market. However, the major concerns for the growth of this market are the requirement of huge capital investments and lack of skilled personnel for carrying out the high content screening process.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=157543946
The global cell analysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period, followed by Europe. Over the next five years, the growth of the global market in the Asian region is likely to be centered at China, Japan, Singapore, and India. This growth will be driven by government support for the growth of innovative technologies and the rising demand for outsourcing of drug discovery services.
The major players in the market include Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Sigma Aldrich (U.S.), Agilent Technologies (U.S.), Merck KGaA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), and Promega Corporation (U.S.), among others.
Browse related reports:
Flow Cytometry Market by Technology (Cell &
Bead-based), Products & Services (Reagents, Instruments, Software, &
Accessories), Application (Research & Clinical), End User (Commercial
Organizations & Diagnostics Laboratories) - Global Forecasts to 2018
Microfluidics Market By Materials (Polymers,
Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on
Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps),
IVD (POC) - Global Trends & Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets